Minjun Chen

5.6k citations

104 papers · 4.0k indexed · 2 hit papers · h-index 35

Impact in

Pharmacology top 0.1%
- Drug-Induced Hepatotoxicity and Protection
- Pharmacogenetics and Drug Metabolism
Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria

Papers in ⓘ

Pharmacology 46
- Drug-Induced Hepatotoxicity and Protection 40
- Pharmacogenetics and Drug Metabolism 34
Molecular Medicine 12
- Antibiotic Resistance in Bacteria 12

Co-authors: Weida Tong (37 shared papers)Jürgen Borlak (14 shared papers)Ayako Suzuki (7 shared papers)Hong Fang (11 shared papers)Huixiao Hong (13 shared papers)Hui Wang (15 shared papers)Shraddha Thakkar (4 shared papers)Raúl J. Andrade (6 shared papers)
Journals: Antimicrobial Agents and Chemotherapy (7 papers)Diagnostic Microbiology and Infectious Disease (5 papers)Drug Discovery Today (4 papers)Toxicological Sciences (4 papers)Scientific Reports (3 papers)
Partner nations: United States China Germany

In The Last Decade

Minjun Chen

98 papers receiving 3.9k citations

Hit Papers

align trajectories log scale

DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans 2016 · 267 citations

Peers

Countries citing papers authored by Minjun Chen

Since Specialization

Citations

This map shows the geographic impact of Minjun Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minjun Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minjun Chen more than expected).

Fields of papers citing papers by Minjun Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minjun Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minjun Chen. The network helps show where Minjun Chen may publish in the future.

Co-authors

The 25 scholars most cited alongside Minjun Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Minjun Chen Line = papers co-authored together Minjun Chen links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 104 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	FDA-approved drug labeling for the study of drug-induced liver injury Drug Discovery Today ·Minjun Chen, Vikrant Vijay, Qiang Shi, Zhichao Liu, Hong Fang, Weida Tong Hit paper breakdown →	2011	296
2	Drug-induced liver injury: Interactions between drug properties and host factors Journal of Hepatology ·Minjun Chen, Ayako Suzuki, Jürgen Borlak, Raúl J. Andrade, M. Isabel Lucena	2015	289
3	DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans Drug Discovery Today ·Minjun Chen, Ayako Suzuki, Shraddha Thakkar, Ke Yu, Chuchu Hu, Weida Tong Hit paper breakdown →	2016	267
4	High lipophilicity and high daily dose of oral medications are associated with significant risk for drug-induced liver injury Hepatology ·Minjun Chen, Jürgen Borlak, Weida Tong	2012	262
5	Molecular Evidence for Spread of Two Major Methicillin-Resistant Staphylococcus aureus Clones with a Unique Geographic Distribution in Chinese Hospitals Antimicrobial Agents and Chemotherapy ·Yudong Liu, Hui Wang, Na Du, En-hua Shen, Hongbin Chen, Junqi Niu, Huifen Ye, Minjun Chen	2008	145
6	Molecular Epidemiology of Clinical Isolates of Carbapenem-Resistant Acinetobacter spp. from Chinese Hospitals Antimicrobial Agents and Chemotherapy ·Hui Wang, Ping Guo, Hongli Sun, He Wang, Qiwen Yang, Minjun Chen, Yingchun Xu, Yuanjue Zhu	2007	124
7	A Decade of Toxicogenomic Research and Its Contribution to Toxicological Science Toxicological Sciences ·Minjun Chen, Min Zhang, Jürgen Borlak, Weida Tong	2012	109
8	Predicting Hepatotoxicity Using ToxCastin VitroBioactivity and Chemical Structure Chemical Research in Toxicology ·Jie Liu, Kamel Mansouri, Richard Judson, Matthew T. Martin, Huixiao Hong, Minjun Chen, Xiaowei Xu, Russell S. Thomas, Imran Shah	2015	108
9	High Daily Dose and Being a Substrate of Cytochrome P450 Enzymes Are Two Important Predictors of Drug-Induced Liver Injury Drug Metabolism and Disposition ·Ke Yu, Xingchao Geng, Minjun Chen, Jie Zhang, Bingshun Wang, Katarina Ilić, Weida Tong	2014	107
10	A review on machine learning methods forin silicotoxicity prediction Journal of Environmental Science and Health Part C ·Gabriel Idakwo, Joseph Luttrell, Minjun Chen, Huixiao Hong, Zhaoxian Zhou, Ping Gong, Chaoyang Zhang	2018	98
11	Toward Predictive Models for Drug-Induced Liver Injury in Humans: Are we There Yet? Biomarkers in Medicine ·Minjun Chen, Halil Bişğin, Lillian Tong, Huixiao Hong, Hong Fang, Jürgen Borlak, Weida Tong	2014	96
12	Metabolic profiling using combined GC–MS and LC–MS provides a systems understanding of aristolochic acid‐induced nephrotoxicity in rat FEBS Letters ·Yan Ni, Mingming Su, Yunping Qiu, Minjun Chen, Yuming Liu, Aihua Zhao, Wei Jia	2007	92
13	Quantitative Structure-Activity Relationship Models for Predicting Drug-Induced Liver Injury Based on FDA-Approved Drug Labeling Annotation and Using a Large Collection of Drugs Toxicological Sciences ·Minjun Chen, Huixiao Hong, Hong Fang, Reagan Kelly, Guangxu Zhou, Jürgen Borlak, Weida Tong	2013	85
14	ArrayTrack: An FDA and Public Genomic Tool Methods in molecular biology ·Hong Fang, Stephen Harris, Zhenjiang Su, Minjun Chen, Feng Qian, Leming Shi, Roger Perkins, Weida Tong	2009	71
15	Development of Decision Forest Models for Prediction of Drug-Induced Liver Injury in Humans Using A Large Set of FDA-approved Drugs Scientific Reports ·Huixiao Hong, Shraddha Thakkar, Minjun Chen, Weida Tong	2017	69
16	Outcome of cephalosporin treatment of bacteremia due to CTX-M–type extended-spectrum β-lactamase–producing Escherichia coli Diagnostic Microbiology and Infectious Disease ·Bin Cao, Wang Hui, Zhu Ren-yuan, Yongzhong Ning, Xiu-li Xie, Yingchun Xu, Zhu Yuanjue, Minjun Chen	2006	66
17	Phenotypic and Genotypic Characterization of Enterobacteriaceae with Decreased Susceptibility to Carbapenems: Results from Large Hospital-Based Surveillance Studies in China Antimicrobial Agents and Chemotherapy ·Qiwen Yang, Hui Wang, Hongli Sun, Hongbin Chen, Yingchun Xu, Minjun Chen	2009	65
18	A Model to predict severity of drug‐induced liver injury in humans Hepatology ·Minjun Chen, Jürgen Borlak, Weida Tong	2016	63
19	Clinical Isolates of Enterobacteriaceae Producing Extended-Spectrum β-Lactamases: Prevalence of CTX-M-3 at a Hospital in China Antimicrobial Agents and Chemotherapy ·Hui Wang, Swathi Kelkar, Weiyuan Wu, Minjun Chen, John P. Quinn	2003	60
20	Antimicrobial resistance trends among 5608 clinical Gram-positive isolates in China: results from the Gram-Positive Cocci Resistance Surveillance program (2005–2010) Diagnostic Microbiology and Infectious Disease ·Chunjiang Zhao, Hongli Sun, Hui Wang, Yudong Liu, Bijie Hu, Yunsong Yu, Ziyong Sun, Yunzhuo Chu, Bin Cao, Kang Liao, Jin’e Lei, Zhidong Hu, Liyan Zhang, Xiaobing Zhang, Yingchun Xu, Zhanwei Wang, Minjun Chen	2012	59

About Minjun Chen

Minjun Chen is a scholar working on Pharmacology, Molecular Medicine, Applied Microbiology and Biotechnology, Computational Theory and Mathematics and Clinical Biochemistry, having authored 104 papers that have together received 4.0k indexed citations. Recurring topics across this work include Drug-Induced Hepatotoxicity and Protection (40 papers), Pharmacogenetics and Drug Metabolism (34 papers), Computational Drug Discovery Methods (24 papers), Liver Disease Diagnosis and Treatment (14 papers), Antibiotic Resistance in Bacteria (12 papers), Drug Transport and Resistance Mechanisms (10 papers), Antimicrobial Resistance in Staphylococcus (9 papers) and Bacterial biofilms and quorum sensing (8 papers). The work is most often cited by research in Pharmacology (1.5k citations), Molecular Medicine (441 citations), Applied Microbiology and Biotechnology (121 citations), Computational Theory and Mathematics (893 citations) and Hepatology (320 citations). Minjun Chen has collaborated with scholars based in United States, China and Germany. Frequent co-authors include Weida Tong, Jürgen Borlak, Ayako Suzuki, Hong Fang, Huixiao Hong, Hui Wang, Shraddha Thakkar, Raúl J. Andrade, M. Isabel Lucena and Ke Yu. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Diagnostic Microbiology and Infectious Disease, Drug Discovery Today, Toxicological Sciences and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact